CDK4/6 inhibitor and doxorubicin synergistically inhibit breast cancer bone metastasis and enhance T-cell targeted therapy

• Xinming Su,
• Takayuki Kobayashi,
• Jingyu Xiang,
• Yalin Xu,
• Ayesha N. Shajahan-Haq,
• Mahta Mardani,
• Suleyman Noordeen,
• Kaylee O'Donnell,
• Kristin A. Kwakwa,
• Francesca Fontana,
• Deborah J. Veis,
• Gregory M. Lanza,
• Katherine N. Weilbaecher

Affiliations

Xinming Su

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Takayuki Kobayashi

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Jingyu Xiang

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Yalin Xu

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Ayesha N. Shajahan-Haq

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, 20057, USA

Mahta Mardani

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Suleyman Noordeen

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Kaylee O'Donnell

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Kristin A. Kwakwa

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Francesca Fontana

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Deborah J. Veis

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Musculoskeletal Research Center, Histology and Morphometry Core, Washington University School of Medicine, St. Louis, MO, 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA

Gregory M. Lanza

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA

Katherine N. Weilbaecher

Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO, 63110, USA